Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Some breast cancer chemotherapy can cause permanent hair loss.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

The drug combination was safe and showed promise in treating advanced tumors.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Blocking Sonic Hedgehog signaling may help manage hair loss from chemotherapy.

5-Fluorouracil causes hair loss by blocking signals needed for hair growth.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.